Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients

被引：0
|
作者：
Nashan, Bjorn [1 ]
Schemmer, Peter [1 ]
Braun, Felix [1 ]
Dworak, Markus [1 ]
Wimmer, Peter [1 ]
Schlitt, Hans [1 ]
机构：
[1] Hephaistos Study Grp, Nurnberg, Germany
来源：
TRANSPLANTATION | 2015年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-270
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [11] Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
    Bjorn Nashan
    Peter Schemmer
    Felix Braun
    Markus Dworak
    Peter Wimmer
    Hans Schlitt
    Trials, 16
  • [12] Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
    Nashan, Bjorn
    Schemmer, Peter
    Braun, Felix
    Dworak, Markus
    Wimmer, Peter
    Schlitt, Hans
    TRIALS, 2015, 16
  • [13] Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus.
    Braun, F.
    Schemmer, P.
    Schlitt, H.
    Pascher, A.
    Klein, C.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Nashan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 556 - 556
  • [14] EVALUATING THE EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS: H2307 STUDY DESIGN
    Sips, C.
    Suh, K. S.
    Joh, J. W.
    Yoshizumi, T.
    Lee, W. C.
    Genyk, Y.
    Martzloff, E. -D.
    Wang, Z.
    Lopez, P.
    Grant, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S858 - S859
  • [15] Efficacy and Safety of Everolimus With Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplant: Design of a Randomized Study
    Grant, D.
    Levy, G.
    Song, G.
    Chen, C.
    Lee, W.
    Joh, J.
    Speziale, A.
    Rauer, B.
    Wang, Z.
    Junge, G.
    Uemoto, S.
    Suh, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 781 - 782
  • [16] Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 de Novo Liver Transplant Recipients - Results at 12 Months
    De Simone, P.
    Nevens, F.
    Duvoux, C.
    Koneru, B.
    McCormack, L.
    McCaughan, G.
    Navasa, M.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    TRANSPLANTATION, 2012, 94 (10) : 220 - 220
  • [17] Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update
    Filipponi, F.
    De Carlis, L.
    Metselaar, H. J.
    Nevens, F.
    Saliba, F.
    Junge, G.
    LIVER TRANSPLANTATION, 2010, 16 (06) : S132 - S133
  • [18] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS AND EARLY STEROID ELIMINATION REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTH DATA FROM THE CRADLE STUDY.
    Toenshoff, B.
    Ettenger, R.
    Christian, M.
    Bjerre, A.
    Strologo, L. D.
    Marks, S. D.
    Pape, L.
    Martzloff, E-D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 1 - 1
  • [19] Efficacy and Safety of Everolimus With Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplant: Design of a Randomized Study.
    Grant, D.
    Levy, G.
    Song, G.
    Chen, C.
    Lee, W.
    Joh, J.
    Speziale, A.
    Rauer, B.
    Wang, Z.
    Junge, G.
    Uemoto, S.
    Suh, K.
    TRANSPLANTATION, 2014, 98 : 781 - 782
  • [20] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    De Simone, Paolo
    Duvoux, Christophe
    Nevens, Frederik
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    HEPATOLOGY, 2013, 58 (06) : 1383A - 1383A
12345